Health Catalyst Third Quarter 2024 Earnings: EPS Misses Expectations

Simply Wall St.11-09

Health Catalyst (NASDAQ:HCAT) Third Quarter 2024 ResultsKey Financial Results Revenue: US$76.4m (up 3.5% from 3Q 2023). Net loss: US$14.7m (loss narrowed by 33% from 3Q 2023). US$0.24 loss per share (...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2482540486?lang=en_US&edition=fundamental","thumbnail":"https://images.simplywall.st/asset/industry/9551730-choice2-main-header/1585186975683","is_english":true,"pubTime":"2024-11-09 22:28","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2482540486","market":"us","top_or_hot":-1,"title":"Health Catalyst Third Quarter 2024 Earnings: EPS Misses Expectations","media":"Simply Wall St.","content":"<div>\n<p>Health Catalyst (NASDAQ:HCAT) Third Quarter 2024 ResultsKey Financial Results Revenue: US$76.4m (up 3.5% from 3Q 2023). Net loss: US$14.7m (loss narrowed by 33% from 3Q 2023). US$0.24 loss per share (...</p>\n\n<a href=\"https://simplywall.st/stocks/us/healthcare/nasdaq-hcat/health-catalyst/news/health-catalyst-third-quarter-2024-earnings-eps-misses-expec\">Source Link</a>\n\n</div>\n","source":"simplywall_highlight","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Health Catalyst Third Quarter 2024 Earnings: EPS Misses Expectations</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nHealth Catalyst Third Quarter 2024 Earnings: EPS Misses Expectations\n</h2>\n\n<h4 class=\"meta\">\n\n\n2024-11-09 22:28 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://simplywall.st/stocks/us/healthcare/nasdaq-hcat/health-catalyst/news/health-catalyst-third-quarter-2024-earnings-eps-misses-expec><strong>Simply Wall St.</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Health Catalyst (NASDAQ:HCAT) Third Quarter 2024 ResultsKey Financial Results Revenue: US$76.4m (up 3.5% from 3Q 2023). Net loss: US$14.7m (loss narrowed by 33% from 3Q 2023). US$0.24 loss per share (...</p>\n\n<a href=\"https://simplywall.st/stocks/us/healthcare/nasdaq-hcat/health-catalyst/news/health-catalyst-third-quarter-2024-earnings-eps-misses-expec\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"HCAT","symbol_name":"Health Catalyst, Inc.","start_time":0,"source_url":"https://simplywall.st/stocks/us/healthcare/nasdaq-hcat/health-catalyst/news/health-catalyst-third-quarter-2024-earnings-eps-misses-expec","article_id":"2482540486","we_media_id":null,"thumbnails":["https://images.simplywall.st/asset/industry/9551730-choice2-main-header/1585186975683"],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2482540486","pubTimestamp":1731162539,"sourceInfo":{"source_id":"simplywall_highlight","name":"Simply Wall St."},"weMediaInfo":null,"summary":"Health Catalyst ( NASDAQ:HCAT ) Third Quarter 2024 Results Key Financial Results Revenue: US$76.4m (up 3.5% from 3Q...","collect":0,"end_time":0,"defaultTopTitle":"simplywall.st","property":["earning"],"viewcount":null,"language":"en","relate_stocks":{"HCAT":"Health Catalyst, Inc."},"translate_title":"Health Catalyst 2024年第三季度收益：每股收益未达预期","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"HCAT":0.9},"content_text":"Health Catalyst (NASDAQ:HCAT) Third Quarter 2024 ResultsKey Financial Results Revenue: US$76.4m (up 3.5% from 3Q 2023). Net loss: US$14.7m (loss narrowed by 33% from 3Q 2023). US$0.24 loss per share (improved from US$0.39 loss in 3Q 2023).  NasdaqGS:HCAT Earnings and Revenue Growth November 9th 2024 All figures shown in the chart above are for the trailing 12 month (TTM) period Health Catalyst EPS Misses Expectations  Revenue was in line with analyst estimates.  Earnings per share (EPS) missed analyst estimates by 8.5%.      Looking ahead, revenue is forecast to grow 10% p.a. on average during the next 3 years, compared to a 9.9% growth forecast for the Healthcare Services industry in the US.    Performance of the American Healthcare Services industry.  The company's shares are up 7.0% from a week ago.   Risk Analysis We should say that we've discovered 2 warning signs for Health Catalyst that you should be aware of before investing here. Valuation is complex, but we're here to simplify it.Discover if Health Catalyst might be undervalued or overvalued with our detailed analysis, featuring fair value estimates, potential risks, dividends, insider trades, and its financial condition.Access Free AnalysisHave feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.","kind":null,"is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"-1","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.29.1","shortVersion":"4.29.1","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2482540486"}